UK lowers new medicine rebate scheme to 14.5% for 2026 – Endpoints News
UK lowers new medicine rebate scheme to 14.5% for 2026 Endpoints NewsWhat will be the cost of Keir Starmer’s…
AAH Pharmaceuticals CEO David Bound to step down
The chief executive of AAH Pharmaceuticals David Bound, has decided to step down and will leave the organisation…
U.S.-U.K. Negotiations Could Lead To Higher Drug Spending In Britain
The U.K.’s National Institute for Health and Care Excellence may raise the cost-effectiveness threshold for the first time…